FierceMedTech names Potrero Medical as one of its “Fierce 15” Med Tech Companies of 2018

San Francisco, CA – February 11, 2019 – Potrero Medical announced today that it has been named by FierceMedTech as one of 2018’s Fierce 15 medtech companies, designating it as one of the most promising private med tech companies in the industry. 

“Potrero Medical’s work is a great example of applying technical engineering to help solve issues that still persist with tried-and-true medical devices” shared Conor Hale, associate editor for FierceMedtech and FierceBiotech.

Every year, FierceMedTech evaluates hundreds of private companies from around the world for its annual Fierce 15 list, which is based on a variety of factors such as: strength of technology, partnerships, venture backers, and competitive market positioning.

Out of hundreds of submissions, Potrero Medical was selected to join this prestigious list of exciting, high-growth companies.

After winning a pitch competition at SXSW and closing an oversubscribed Series C funding round in 2018, Potrero’s momentum continued into the new year by quickly expanding their commercial business through their strategic partner, Medline Industries.

With various clinical studies underway, Potrero is also building on top of its current platform technology. In addition to acute kidney injury, the company is developing its technology to tackle additional diseases such as intra-abdominal hypertension.

Potrero Medical’s flagship technology, The Accuryn Monitoring System®, is currently being used in hospitals today as a diagnostic tool for precise, real-time measurement of intra-abdominal pressure (IAP), urine output (UO) and core body temperature.

“Having our team selected to be included in a group of such exciting and innovative companies is an honor. Our technology is already in the field making an impact and we have plans to do even more” explains Potrero Medical CEO Joe Urban.

Their team is currently developing a predictive health platform to help medical teams better predict adverse outcomes in critical care settings.

“We are committed to our mission in developing technology that helps give doctors and nurses more freedom to spend time with patients rather than capturing and managing data”  concludes Joe Urban.

The Fierce 15 celebrates the spirit of being “fierce” – championing innovation and creativity, even in the face of intense competition. This year’s full list of winners can be viewed online at https://www.fiercebiotech.com/special-report/fiercemedtech-s-2018-fierce-15.

About FierceMedTech

FierceMedTech keeps biopharma executives, device developers, engineers, and researchers updated on the must-know news, trends and developments in medical technology.  More than 90,000 top industry professionals rely on FierceMedTech for an insider briefing on the day’s top stories.

About Potrero Medical

 Potrero Medical, Inc. is a predictive health company transforming patient care using predictive analytics for early detection of critical illnesses. As a spinout of medical device incubator Theranova LLC, Potrero Medical was founded with a mission to improve patient care with the latest advances in artificial intelligence and sensors.  Potrero Medical is headquartered in Hayward, CA. For more information, visit www.potreromed.com or follow on LinkedIn.

Comment

There is no comment on this post. Be the first one.

Leave a Reply